Petersen, E;
Hui, DS;
Nachega, JB;
Ntoumi, F;
Goletti, D;
Aklillu, E;
Sharma, A;
... Zumla, A; + view all
(2023)
End of the Bedaquiline patent – a crucial development for moving forward affordable drugs, diagnostics, and vaccines for infectious diseases in low- and middle-income countries.
International Journal of Infectious Diseases
, 131
pp. 180-182.
10.1016/j.ijid.2023.04.386.
Preview |
PDF
1-s2.0-S1201971223005179-main.pdf - Published Version Download (273kB) | Preview |
| Type: | Article |
|---|---|
| Title: | End of the Bedaquiline patent – a crucial development for moving forward affordable drugs, diagnostics, and vaccines for infectious diseases in low- and middle-income countries |
| Location: | Canada |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ijid.2023.04.386 |
| Publisher version: | https://doi.org/10.1016/j.ijid.2023.04.386 |
| Language: | English |
| Additional information: | This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ). |
| Keywords: | Humans, Developing Countries, Vaccines, Costs and Cost Analysis, Communicable Diseases |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10169900 |
Archive Staff Only
 |
View Item |
